(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ: ARCT) slid by a staggering 25.62% in 30 days from $20.64 to $15.35 at 14:43 EST on Thursday, after three successive sessions in a row of gains. NASDAQ is rising 0.58% to $11,117.17, following the last session’s downward trend.
Arcturus Therapeutics’s last close was $15.43, 76.26% under its 52-week high of $65.00.
Volume
Today’s last reported volume for Arcturus Therapeutics is 416079 which is 42.46% below its average volume of 723237.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 51.9% for the present quarter and a decline by 42.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 15.5% and 22.4%, respectively.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 158.9%, now sitting on 12.36M for the twelve trailing months.
Volatility
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 7.98%, 0.41%, and 6.78%, respectively.
Arcturus Therapeutics’s highest amplitude of average volatility was 7.98% (last week), 8.27% (last month), and 6.78% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be oversold (<=20).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $15.35 at 14:43 EST, way below its 52-week high of $65.00 and way above its 52-week low of $11.70.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s value is way under its 50-day moving average of $19.46 and way under its 200-day moving average of $31.67.
More news about Arcturus Therapeutics (ARCT).
